Quality Risk Management And The Draft Annex 1 Revision — What To Expect – Hal Baseman and Kelly Waldron, Ph.D.
December 16, 2020
Part of the ValID Insight series, a timely look at issues and insights shaping the regulated pharmaceutical industry worldwide.